Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer

Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer characterized by early metastasis and high mortality. In recent years, monotherapy and combination therapy of amrubicin with cisplatin or carboplatin has been actively studied and shown promise for the treatment of extensive di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Qian, Zhan, Jinbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738252/
https://www.ncbi.nlm.nih.gov/pubmed/23946645
http://dx.doi.org/10.2147/DDDT.S41910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738252/
https://www.ncbi.nlm.nih.gov/pubmed/23946645
http://dx.doi.org/10.2147/DDDT.S41910

Ejemplares similares